Altimmune, Inc. (ALT)
4.87
-0.05
(-1.02%)
USD |
NASDAQ |
Feb 06, 16:00
4.89
+0.02
(+0.41%)
After-Hours: 20:00
Altimmune SG&A Expense (TTM) : 22.68M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 75.56M |
| Actinium Pharmaceuticals, Inc. | 15.79M |
| Aldeyra Therapeutics, Inc. | 9.186M |
| Viking Therapeutics, Inc. | 52.36M |
| Seres Therapeutics, Inc. | 44.08M |